CHARLEYS FUND INC: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
CHARLEYS FUND INC (EIN 20-2014968)
Tax period
2018-01-01 to 2018-12-31
Filed
2019-11-13
IRS object ID
201913179349309551
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2019-11-13T18:56:26-06:00ReturnTs
Tax Period End2018-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN133628255PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CONDON O'MEARA MCGINTY & DONNELLY LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1ONE BATTERY PARK PLAZA 7TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2018-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN202014968EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CHARLEY'S FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCHARBusinessNameControlTxt
Phone4135280400PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1635 MAIN STREET SUITE 3AddressLine1Txt
CityGREAT BARRINGTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01230ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonEARL KRAMERPersonNm
Person TitleTREASURERPersonTitleTxt
Phone4135280400PhoneNum
Signature2019-11-08SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJAMES J REILLYPreparerPersonNm
PTINP00183769PTIN
Phone2126617777PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address184.74.172.82IPv4AddressTxt
FieldValueIRS element (for citing)
IP2019-11-08IPDt
IP Tm11:23:08IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdDA39A3EE5E6B4B0D3255BFEF95601890AFD80709AtSubmissionCreationDeviceId
At Submission Filing Device Id22603B5F3D0F044F5E1D98A58B2AA5892463CC73AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2020-03-31 21:24:44ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerEARL KRAMERPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1635 MAIN STREET SUITE 3AddressLine1Txt
CityGREAT BARRINGTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01230ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$2,812,052GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.CHARLEYSFUND.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2004FormationYr
Legal Domicile StateMALegalDomicileStateCd
Activity Or MissionTO ACCELERATE THE DEVELOPMENT OF LIFE-SAVING TREATMENTS FOR DUCHENNE MUSCULAR DYSTROPHY "DMD"ActivityOrMissionDesc
Voting Members Governing Body8VotingMembersGoverningBodyCnt
Voting Members Independent7VotingMembersIndependentCnt
Total Employee4TotalEmployeeCnt
Total Volunteers8TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,415,266PYContributionsGrantsAmt
CY Contributions Grants$2,757,831CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$4,682PYInvestmentIncomeAmt
CY Investment Income$12,225CYInvestmentIncomeAmt
PY Other Revenue$1,131PYOtherRevenueAmt
CY Other Revenue-$1,312CYOtherRevenueAmt
PY Total Revenue$1,421,079PYTotalRevenueAmt
CY Total Revenue$2,768,744CYTotalRevenueAmt
PY Grants And Similar Paid$830,522PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$1,522,481CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$521,216PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$478,333CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$281,135CYTotalFundraisingExpenseAmt
PY Other Expenses$289,753PYOtherExpensesAmt
CY Other Expenses$260,701CYOtherExpensesAmt
PY Total Expenses$1,641,491PYTotalExpensesAmt
CY Total Expenses$2,261,515CYTotalExpensesAmt
PY Revenues Less Expenses-$220,412PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$507,229CYRevenuesLessExpensesAmt
Total Assets BOY$5,479,080TotalAssetsBOYAmt
Total Assets EOY$5,773,778TotalAssetsEOYAmt
Total Liabilities BOY$436,974TotalLiabilitiesBOYAmt
Total Liabilities EOY$224,443TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$5,042,106NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$5,549,335NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionCHARLEY'S FUND'S SINGULAR MISSION IS TO SUPPORT THE DEVELOPMENT OF TREATMENTS AND A CURE FOR DUCHENNE MUSCULAR DYSTROPHY (DMD). WE IDENTIFY AND DIRECT FUNDING TO THE MOST COMPELLING RESEARCH AND TREATMENT PROGRAMS RELATED TO DMD AND, (CONT. ON SCH. O.)MissionDesc
Significant New Program SrvcYes (1)SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,330,017ExpenseAmt
Grant$1,300,000GrantAmt
DescSEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$125,000ExpenseAmt
Grant$125,000GrantAmt
DescTHE GRANT TO AKASHI THERAPEUTICS, INC., WAS TO SUPPORT FOR THE CONTINUED DEVELOPMENT OF THEIR RESEARCH PIPELINE, INCLUDING CLINICAL DEVELOPMENT OF HT-100 (DELAYED RELEASE HALOFUGINONE), AN ORALLY AVAILABLE SMALL MOLECULE DEVELOPED TO REDUCE FIBROSIS AND INFLAMMATION AND PROMOTE HEALTHY MUSCLE REGENERATION IN BOYS WITH DMD; AN ORAL SARM (SELECTIVE ANDROGEN RECEPTOR MODULATOR), AND AT-300, A NEW THERAPY THAT HAS THE POTENTIAL TO INHIBIT THE CALCIUM INFLUX THAT RESULTS FROM THE LACK OF DYSTROPHIN IN BOYS WITH DMD.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$179,648ExpenseAmt
Grant$97,481GrantAmt
DescSEE SCHEDULE ODesc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$224,590ExpenseAmt
DescOTHERDesc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$224,590TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses$1,859,255TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent EndowmentsYes (1)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related InvstYes (1)ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control Ent0TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document13IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee4EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Taxable Distributions0TaxableDistributionsInd
Distribution To Donor0DistributionToDonorInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members8GoverningBodyVotingMembersCnt
Independent Voting Member7IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint VentureYes (1)InvestmentInJointVentureInd
Written Policy Or Procedure0WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SARAH DONALDSONTHE FUNDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4135280400PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1635 MAIN ST STE 3AddressLine1Txt
CityGREAT BARRINGTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01230ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (9 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
BENJAMIN SECKLER MD
BOARD CHAIRMAN15.00Yes (X)Yes (X)$0$0$0
EARL KRAMER
TREASURER2.00Yes (X)Yes (X)$0$0$0
KAREN CLIMO
CLERK2.00Yes (X)Yes (X)$0$0$0
KATHE KRAMER CHASE
BOARD MEMBER2.00Yes (X)$0$0$0
RANDY REIFF
BOARD MEMBER2.00Yes (X)$0$0$0
TRACY KRAMER SECKLER
BOARD MEMBER40.00Yes (X)$71,510$0$0
ELLEN WILNER
BOARD MEMBER2.00Yes (X)$0$0$0
MARK AVAGLIANO
BOARD MEMBER2.00Yes (X)$0$0$0
LAURA DALLE PAZZE
PRESIDENT & CHIEF OPERATING OFFICER55.00Yes (X)$224,523$0$6,737
FieldValueIRS element (for citing)
Total Reportable Comp From Org$296,033TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$6,737TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K1IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
All Other Contributions$2,757,831AllOtherContributionsAmt
Noncash Contributions$42,225NoncashContributionsAmt
Total Contributions$2,757,831TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$12,477TotalRevenueColumnAmt
Exclusion$12,477ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$41,973SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$42,225SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$252SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$252TotalRevenueColumnAmt
Exclusion-$252ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$183GrossSalesOfInventoryAmt
Cost Of Goods Sold$1,083CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$900TotalRevenueColumnAmt
Related Or Exempt Func Income-$900RelatedOrExemptFuncIncomeAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescLOSS ON INVESTEMNT IN LLCDesc
Business900099BusinessCd
Total Revenue Column-$412TotalRevenueColumnAmt
Exclusion-$412ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total-$412OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,768,744TotalRevenueColumnAmt
Related Or Exempt Func Income-$900RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$11,813ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,522,481TotalAmt
Program Services$1,522,481ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$302,770TotalAmt
Program Services$129,615ProgramServicesAmt
Management And General$53,093ManagementAndGeneralAmt
Fundraising$120,062FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$131,745TotalAmt
Program Services$57,027ProgramServicesAmt
Management And General$22,820ManagementAndGeneralAmt
Fundraising$51,898FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$16,706TotalAmt
Program Services$3,656ProgramServicesAmt
Management And General$4,503ManagementAndGeneralAmt
Fundraising$8,547FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$27,112TotalAmt
Program Services$10,816ProgramServicesAmt
Management And General$4,755ManagementAndGeneralAmt
Fundraising$11,541FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$10,062TotalAmt
Program Services$8,912ProgramServicesAmt
Management And General$707ManagementAndGeneralAmt
Fundraising$443FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$22,700TotalAmt
Program Services$650ProgramServicesAmt
Management And General$22,050ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$1,325TotalAmt
Management And General$1,325ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$19,853TotalAmt
Program Services$4,454ProgramServicesAmt
Fundraising$15,399FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$44,877TotalAmt
Program Services$2,492ProgramServicesAmt
Management And General$2,008ManagementAndGeneralAmt
Fundraising$40,377FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$20,871TotalAmt
Program Services$8,023ProgramServicesAmt
Management And General$3,361ManagementAndGeneralAmt
Fundraising$9,487FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$18,844TotalAmt
Program Services$14,911ProgramServicesAmt
Management And General$758ManagementAndGeneralAmt
Fundraising$3,175FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,100TotalAmt
Program Services$1,100ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$364TotalAmt
Management And General$364ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$6,706TotalAmt
Program Services$2,236ProgramServicesAmt
Management And General$2,235ManagementAndGeneralAmt
Fundraising$2,235FundraisingAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
SCIENTIFIC CONSULTING$74,620$74,620
OTHER$39,379$18,262$3,146$17,971

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$2,261,515TotalAmt
Program Services$1,859,255ProgramServicesAmt
Management And General$121,125ManagementAndGeneralAmt
Fundraising$281,135FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$9,339BOYAmt
EOY$10,103EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,998,113BOYAmt
EOY$1,106,648EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$247,111BOYAmt
EOY$1,432,833EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$14,021BOYAmt
EOY$12,938EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$4,248BOYAmt
EOY$4,234EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$10,485LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$9,688LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,161BOYAmt
EOY$797EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$3,202,537BOYAmt
EOY$3,202,775EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$2,550BOYAmt
EOY$3,450EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,479,080BOYAmt
EOY$5,773,778EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$26,011BOYAmt
EOY$30,358EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$410,963BOYAmt
EOY$194,085EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$436,974BOYAmt
EOY$224,443EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,947,485BOYAmt
EOY$4,299,335EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$94,621BOYAmt
EOY$1,250,000EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,042,106BOYAmt
EOY$5,549,335EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,479,080BOYAmt
EOY$5,773,778EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$507,229ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,249,979CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,550,470CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,054,965CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,415,266CurrentTaxYearMinus1YearAmt
Current Tax Year$2,757,831CurrentTaxYearAmt
Total$8,028,511TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,249,979CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,550,470CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,054,965CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,415,266CurrentTaxYearMinus1YearAmt
Current Tax Year$2,757,831CurrentTaxYearAmt
Total$8,028,511TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$1,620,690SubstantialContributorsTotAmt
Public Support Total170$6,407,821PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$126,004CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,178CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,119,820CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,746CurrentTaxYearMinus1YearAmt
Current Tax Year$11,152CurrentTaxYearAmt
Total$3,262,900TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus1 Year$38CurrentTaxYearMinus1YearAmt
Total$38TotalAmt
FieldValueIRS element (for citing)
Total Support$11,291,449TotalSupportAmt
Public Support CY1700.56750PublicSupportCY170Pct
Public Support PY1700.59360PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:FormAndLineReferenceDesc
ExplanationOTHER - 2017 AMOUNT: $ 38.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$94,621BeginningYearBalanceAmt
Contributions$1,825,000ContributionsAmt
Other Expenditures$669,621OtherExpendituresAmt
End Year Balance$1,250,000EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$35,000BeginningYearBalanceAmt
Contributions$205,000ContributionsAmt
Other Expenditures$145,379OtherExpendituresAmt
End Year Balance$94,621EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$64,707BeginningYearBalanceAmt
Contributions$40,000ContributionsAmt
Other Expenditures$69,707OtherExpendituresAmt
End Year Balance$35,000EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Contributions$130,000ContributionsAmt
Other Expenditures$65,293OtherExpendituresAmt
End Year Balance$64,707EndYearBalanceAmt
FieldValueIRS element (for citing)
Term Endowment Balance EOY1.00000TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$10,485OtherCostOrOtherBasisAmt
Depreciation$9,688DepreciationAmt
Book Value$797BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$797TotalBookValueLandBuildingsAmt

Invst Program Related Org InvstProgramRelatedOrgGrp (5 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
INVESTMENT - DMD SOLUTIONS,LLC-$6,667C
INVESTMENT - TCW CATALYST,LLC-$235C
INVESTMENT - WIDE VISION LLC$125,000C
INVESTMENT - DART THERAPEUTICS$84,677C
INVESTMENT - AKASHI THERAPEU.$3,000,000C
FieldValueIRS element (for citing)
Total Book Value Program Rltd$3,202,775TotalBookValueProgramRltdAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART V, LINE 4:FormAndLineReferenceDesc
ExplanationTEMPORARILY RESTRICTED NET ASSETS CONSIST OF CONTRIBUTIONS THAT ARE RESTRICTED BY THE DONOR FOR A SPECIFIC PURPOSE OR RELATE TO FUTURE PERIODS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtRecipient EINRecipientEIN
AKASHI THERAPUTICS LLC
145 FIRST STCAMBRIDGEMA02142N/A$125,000RESEARCH GRANT
CASIMIR LLC
36 CORDAGE PARK CIRCLEPLYMOUTHMA02360N/A$97,481RESEARCH GRANT
UMASS MEMORIAL FOUNDATION
333 SOUTH STSHREWSBURYMA01545501(C)(3)$1,300,000RESEARCH GRANT043108190
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationALL GRANTS ARE PROVIDED UNDER CONTRACTS WITH THE GRANT RECIPIENTS. THE CONTRACTS REQUIRE GRANTEES TO MEET CERTAIN EVENT AND PERFORMANCE MILESTONES AND PERIODIC PROGRESS REPORTS TO CHARLEY'S FUND, INC. ARE REQUIRED. THE BOARD OF DIRECTORS REVIEWS AND APPROVES GRANTS ACCORDING TO THE ORGANIZATION'S POLICY ON FUNDING AND EXPENSE APPROVALS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp

FieldValueIRS element (for citing)
PersonLAURA DALLE PAZZEPersonNm
TitlePRESIDENT & CHIEF OPERATING OFFICERTitleTxt
Base Compensation Filing Org$192,566BaseCompensationFilingOrgAmt
Compensation Based On Rltd Orgs$0CompensationBasedOnRltdOrgsAmt
Bonus Filing Organization$31,957BonusFilingOrganizationAmount
Bonus Related Organizations$0BonusRelatedOrganizationsAmt
Other Compensation Filing Org$0OtherCompensationFilingOrgAmt
Other Compensation Rltd Orgs$0OtherCompensationRltdOrgsAmt
Deferred Compensation Flng Org$0DeferredCompensationFlngOrgAmt
Deferred Comp Rltd Orgs$0DeferredCompRltdOrgsAmt
Nontaxable Benefits Filing Org$6,737NontaxableBenefitsFilingOrgAmt
Nontaxable Benefits Rltd Orgs$0NontaxableBenefitsRltdOrgsAmt
Total Compensation Filing Org$231,260TotalCompensationFilingOrgAmt
Total Compensation Rltd Orgs$0TotalCompensationRltdOrgsAmt
Comp Report Prior990 Filing Org$0CompReportPrior990FilingOrgAmt
Comp Report Prior990 Rltd Orgs$0CompReportPrior990RltdOrgsAmt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution6ContributionCnt
Noncash Contributions Rpt F990$42,225NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
CONT. FROM PART III - LINE 1IMPORTANTLY, AMPLIFY THE IMPACT OF THAT FUNDING WITH STRATEGIC PROBLEM-SOLVING SUPPORT TO BOTH AWARDEES AND THE BROADER DMD RESEARCH COMMUNITY. TO BEAT DMD, IT'S NOT ENOUGH TO FIND THE BEST RESEARCH; WE ALSO MUST PROACTIVELY IDENTIFY AND KNOCK DOWN HURDLES THAT STAND IN THE WAY OF EFFICIENT DRUG DEVELOPMENT. SINCE INCEPTION, WE HAVE DIRECTED ALMOST $45M IN FUNDING TO THESE EFFORTS, LEVERAGING BOTH OUR OWN FUNDING AS WELL AS FUNDING FROM OTHER DMD PATIENT ORGANIZATIONS TO IDENTIFY AND SUPPORT THE BEST SCIENCE IN PURSUIT OF TREATMENTS AND A CURE FOR DMD. IN 2018, WE DEDICATED A TOTAL OF $1,859,254 TO OUR PROGRAMMATIC EFFORTS. OF THIS, $1,522,481 WAS DEDICATED TO GRANTS AND ALLOCATIONS AND $336,773 WAS DEDICATED TO OTHER PROGRAMMATIC EXPENSES.
FORM 990, PART III, LINE 2IN 2018 WE FOUNDED THE DUCHENNE PROGRAM AT UMASS MEDICAL SCHOOL, AN INITIATIVE DESIGNED TO ADVANCE COMPREHENSIVE CARE AND RESEARCH FOR DMD PATIENTS IN THE REGION, ACROSS THE COUNTRY, AND EVEN AROUND THE WORLD. OUR SUPPORT ENABLES THE ESTABLISHMENT OF A BEST-IN-CLASS CLINICAL FACILITY AND PROGRAM THAT ADVANCES OUR MISSION TO STOP DMD BY PURSUING THREE MUTUALLY ENHANCING PILLARS OF WORK: PROVIDING MULTIDISCIPLINARY, INTEGRATIVE CARE TO BOYS LIVING WITH DMD TODAY, HOSTING CUTTING-EDGE CLINICAL TRIALS, AND CONDUCTING ORIGINAL RESEARCH. WE PROVIDED $1.3MM TO UMASS SUPPORT THIS INITIATIVE IN 2018. THE DUCHENNE PROGRAM OPENED ITS DOORS IN JULY.
PART III - LINE 4AIN 2018 WE CREATED THE DUCHENNE PROGRAM AT UMASS MEDICAL SCHOOL. THE PROGRAM IS POWERED BY A UNIQUE COLLABORATION AMONG THE MEDICAL, RESEARCH, AND PATIENT COMMUNITIES. FOUNDING CLINIC DIRECTOR DR. BRENDA WONG, HOST INSTITUTION UMASS MEDICAL CENTER AND MEDICAL SCHOOL, AND CHARLEY'S FUND WORK JOINTLY TO ENSURE THAT THE DUCHENNE PROGRAM DELIVERS WORLD-CLASS RESULTS ON THREE KEY GOALS: DELIVER COMPREHENSIVE, INTEGRATED CARE TO PATIENTS HOST CUTTING-EDGE CLINICAL TRIALS DRIVE ORIGINAL RESEARCH AND DISCOVERIES TO POWER THE NEXT WAVE OF BREAKTHROUGHS THE DUCHENNE PROGRAM ALREADY IN ITS FIRST YEAR IS SEEING MORE PATIENTS THAN ANY OTHER CLINIC IN THE WORLD. IT CURRENTLY HOSTS TWO ACTIVE CLINICAL TRIALS AND IS IN DISCUSSIONS TO ADD MORE. IT ALSO CURRENTLY HAS ONE ORIGINAL RESEARCH PROJECT UNDERWAY AND IS WELL INTO DEVELOPING THE DATABASE THAT WILL PROVIDE A KEY RESOURCE IN FURTHER RESEARCH TO FOLLOW.
PART III - LINE 4CTHROUGH OUR IMPACT INITIATIVE WE WORK WITH PARTNERS IN THE FIELD TO DEVELOP THEIR SCIENTIFIC PROGRAMS AND TO IDENTIFY RESEARCH ROADBLOCKS AND POTENTIAL SOLUTIONS. THE IMPACT INITIATIVE SPEEDS AND IMPROVES ALL RESEARCH NOT JUST ONE PARTICULAR THERAPY BY IDENTIFYING AND THEN SOLVING SYSTEMIC PROBLEMS THAT MAKE DRUG DEVELOPMENT SLOWER, MORE DIFFICULT AND MORE COSTLY. CURRENTLY THE IMPACT INITIATIVE FOCUSES ON THREE AREAS: 1) IMPROVING OUTCOME MEASURES, 2) IMPROVING PRECLINICAL METHODS AND DECISION-MAKING, AND 3) IMPROVING THE DESIGN, EXECUTION, AND ANALYSIS OF CLINICAL TRIALS FOR DMD. WE DEVELOPED THE IMPACT INITIATIVE BECAUSE RIGOROUS SCIENCE UNDERTAKEN WITH URGENCY AND FOCUS IS THE ONLY WAY WE GET TO THE OUTCOMES WE AND ALL DUCHENNE FAMILIES WANT: DRUGS THAT WORK, AND WORK WELL. SOLVING THESE FIELD-WIDE PROBLEMS AND IMPROVING OUR TOOLS AND RESOURCES IS AN ABSOLUTE MUST TO GET RESULTS. OUTCOME MEASURES: ONE ASPECT OF THE DRUG DEVELOPMENT PROCESS THAT CONCERNS US IS THE LACK OF RELIABLE OUTCOME MEASURES THAT CAN DETERMINE THE EFFICACY OF AN INTERVENTION OVER A REASONABLY SHORT PERIOD OF TIME. IN 2018 WE COMMITTED FUNDS TO CASIMIR, LLC WHICH WAS FORMED TO ADDRESS THIS IMPORTANT NEED BY DEVELOPING A SERIES OF OUTCOME MEASURES DESIGNED TO QUANTIFY PATIENT QUALITY OF MOVEMENT USING VIDEOS OF BOYS WITH DMD PERFORMING DAILY TASKS. WITH OUR SUPPORT, CASIMIR HAS PURSUED ACTIVITIES TO DEVELOP AND REFINE THEIR SCORING SYSTEM, GATHER KEY BASELINE DATA NEEDED TO DETERMINE ITS RELIABILITY AND CONCEPT VALIDITY, AND BEGUN ENGAGING WITH THE FDA TO ENSURE ACCEPTANCE OF THIS DEVELOPING TOOL. ALSO, IN 2018, WE CONTINUED OUR SUPPORT FOR ELECTRICAL IMPEDANCE MYOGRAPHY (EIM), COLLABORATING WITH EIM FOUNDER DR. SEWARD RUTKOVE TO ASSESS ITS SUITABILITY AS AN OUTCOME MEASURE FOR DMD. EIM UTILIZES A SMALL, HAND-HELD DEVICE TO RUN A HIGH-FREQUENCY CURRENT THROUGH A MUSCLE. IT IS PAINLESS, RELATIVELY INEXPENSIVE, TAKE SECONDS TO PERFORM AND CAN BE USED ON PATIENTS OF ANY AGE. WITH OUR SUPPORT, DR. RUTKOVE HAS COMPLETED CRITICAL STUDIES TO CONFIRM EIM'S RELIABILITY, CONSISTENCY AND ABILITY TO DIFFERENTIATE HEALTHY MUSCLE FROM DISEASED MUSCLE. PRECLINICAL METHODS: ONE MAJOR REASON WE HAVE TROUBLE TRANSLATING PROMISING RESEARCH RESULTS INTO ACTUAL THERAPIES IS THE SHORTCOMINGS IN HOW PRECLINICAL METHODS AND MODELS ARE USED BY DMD RESEARCHERS. OUR "OF MICE AND MEASURES" PROGRAM (OMAM) IS A COLLABORATIVE, ONGOING EFFORT THAT BRINGS TOGETHER EXPERTS FROM ACADEMIA AND INDUSTRY TO IMPROVE THE DECISION-MAKING PROCESS FOR WHICH DRUGS SHOULD ADVANCE TO CLINICAL TESTING. CLINICAL TRIALS: THE COLLABORATIVE TRAJECTORY ANALYSIS PROJECT (CTAP) IS A COLLABORATIVE EFFORT AMONG KEY STAKEHOLDERS IN THE INDUSTRY, ACADEMIC, AND PATIENT COMMUNITIES TO IMPROVE THE WAY WE DESIGN, EXECUTE, AND ANALYZE CLINICAL TRIALS IN DUCHENNE. IT MAKES USE OF A GROWING BODY OF DMD NATURAL HISTORY AND CLINICAL TRIAL DATA AND CUTTING-EDGE BIOSTATISTICAL ANALYSIS APPROACHES TO IMPROVE OUR UNDERSTANDING OF THE NATURAL HISTORY OF DUCHENNE AND THUS, HOW SPONSORS CAN BETTER DESIGN TRIALS TO IDENTIFY WHEN THEIR TREATMENT SUCCEEDS IN CHANGING THAT NATURAL HISTORY. CTAP WORKS TO PROVIDE 1) ONGOING INVESTIGATION AND PUBLICATION ON KEY QUESTIONS FACING THE FIELD AND IMPACTING CLINICAL TRIAL DESIGN, AND 2) TARGETED SUPPORT FOR SPONSORS DESIGNING AND RUNNING TRIALS TODAY.
FORM 990, PART VI, SECTION A, LINE 2BENJAMIN SECKLER, MD (BOARD CHAIRMAN), IS HUSBAND TO TRACY KRAMER SECKLER (BOARD MEMBER). EARL KRAMER (TREASURER), IS FATHER TO TRACY KRAMER SECKLER (BOARD MEMBER) AND KATHE KRAMER CHASE (BOARD MEMBER). KATHE KRAMER CHASE (BOARD MEMBER), AND TRACY KRAMER SECKLER (BOARD MEMBERS), ARE SISTERS.
FORM 990, PART VI, SECTION B, LINE 11BNO REVIEW WAS OR WILL BE CONDUCTED.
FORM 990, PART VI, SECTION B, LINE 12COFFICERS, DIRECTORS AND KEY EMPLOYEES MUST REVIEW THE POLICY ANNUALLY AND SIGN A DECLARATION THAT THEY HAVE COMPLIED WITH THE POLICY.
FORM 990, PART VI, SECTION B, LINE 15COMPENSATION OF TOP MANAGEMENT AND OFFICERS OF THE ORGANIZATION IS DEVELOPED IN CONSIDERATION OF PERFORMANCE AND REVIEW OF RELEVANT COMPETITIVE BENCHMARKS AND SUBMITTED TO FINANCE BOARD MEMBERS FOR APPROVAL.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1CHARLEY'S FUND VENTURES LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1635 MAINT STREETAddressLine1Txt
CityGREAT BARRINGTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01230ZIPCd
FieldValueIRS element (for citing)
EIN275009330EIN
Primary ActivitiesFUND RAISINGPrimaryActivitiesTxt
Legal Domicile StateMALegalDomicileStateCd
End Of Year Assets$3,085,779EndOfYearAssetsAmt
Direct Controlling NAN/ADirectControllingNACd

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1DARIUS GOES WEST INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1C/O LOGAN SMALLEY 135 TOPS COURTAddressLine1Txt
CityATHENSCityNm
State AbbreviationGAStateAbbreviationCd
ZIP30606ZIPCd
FieldValueIRS element (for citing)
EIN262174272EIN
Primary ActivitiesFUNDRAISINGPrimaryActivitiesTxt
Legal Domicile StateGALegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity Status509 (A) (3)PublicCharityStatusTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdDirect Controlling NADirectControllingNACdPredominant Income TypePredominantIncomeTypeTxtShare Of EOY AssetsShareOfEOYAssetsAmtDisproportionate AllocationsDisproportionateAllocationsIndGeneral Or Managing PartnerGeneralOrManagingPartnerIndEINEINShare Of Total IncomeShareOfTotalIncomeAmt
WIDE VISION DMD CAPITAL LLC
2266 WEST ENDNEW YORKNY10025INVESTMENTMAN/ARELATED$125,00000
DMD SOLUTIONS LLC
635 MAIN STREETGREAT BARRINGTONMA01230INVESTMENTMAN/ARELATED-$6,66700271107747-$81
TCW CATALYST LLC
4904 MERILANE AVEEDINAMN55436INVESTMENTMNN/ARELATED-$23500208875302-$170
DART THERAPEUTICS LLC
635 MAIN STREETGREAT BARRINGTONMA01230INVESTMENTMAN/ARELATED$84,67700-$161

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1AKASHI THERAPEUTICS INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1245 FIRST ST 18TH FLOORAddressLine1Txt
CityCAMBRIDGECityNm
State AbbreviationMAStateAbbreviationCd
ZIP02142ZIPCd
FieldValueIRS element (for citing)
Primary ActivitiesDRUG DEVELOPMENTPrimaryActivitiesTxt
Legal Domicile StateMALegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1CHARLEY'S FUNDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Entity TypeCEntityTypeTxt
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.